These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 5076802)

  • 1. The detection of fibrinogen-fibrin degradation products by means of a new antibody-coated latex particle.
    Garvey MB; Black JM
    J Clin Pathol; 1972 Aug; 25(8):680-2. PubMed ID: 5076802
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of a new anti-fibrinogen-coated latex particle agglutination test in the measurement of serum fibrin degradation products.
    Marder VJ; Cruz GO; Schumer BR
    Thromb Haemost; 1977 Apr; 37(2):183-91. PubMed ID: 577622
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of a direct latex-agglutination technic with the tanned red cell hemagglutination inhibition immunoassay (TRCHII) for semiquantitation of fibrinogen/fibrin degradation products.
    Wilson JE; Thornton RD
    Am J Clin Pathol; 1976 Apr; 65(4):528-32. PubMed ID: 1266814
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparison between radioimmunoassay and other immunological techniques for the measurement of fibrinogen/fibrin degradation products in serum.
    Ratky SM; Martin MJ; Gordon YB; Baker LR; Chard T; Leslie J
    Br J Haematol; 1975 Jun; 30(2):145-9. PubMed ID: 1201206
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of two new assays for determination of serum fibrinogen/fibrin degradation products.
    Sumner K; Feller E; Galanakis DK; Mosesson MW
    Ann Clin Lab Sci; 1979; 9(5):362-7. PubMed ID: 533231
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of fibrinogen antigens with two latex techniques applied to urine concentrates.
    Donati MB; Semeraro N; Vermylen J
    J Clin Pathol; 1973 Oct; 26(10):760-3. PubMed ID: 4201501
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Detection of fibrinogen and fibrin degradation products (FDP) and its clinical significance].
    Fujimaki M; Ikematsu S; Takeuchi I
    Nihon Rinsho; 1973 Apr; 31(4):798-804. PubMed ID: 4580396
    [No Abstract]   [Full Text] [Related]  

  • 8. Detection of fibrin(ogen) degradation products by a latex clumping method.
    Allington MJ
    Scand J Haematol Suppl; 1971; 13():115-9. PubMed ID: 5290675
    [No Abstract]   [Full Text] [Related]  

  • 9. Mechanisms for elevated fibrin/fibrinogen degradation products in acute experimental pulmonary embolism.
    Cade J; Hirsh J; Regoeczi E
    Blood; 1975 Apr; 45(4):563-8. PubMed ID: 1115842
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Latex immunoturbidimetric assay for soluble fibrin complex.
    Hamano A; Umeda M; Ueno Y; Tanaka S; Mimuro J; Sakata Y
    Clin Chem; 2005 Jan; 51(1):183-8. PubMed ID: 15514091
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rapid detection of cross-linked fibrin degradation products in plasma using monoclonal antibody-coated latex particles.
    Elms MJ; Bunce IH; Bundesen PG; Rylatt DB; Webber AJ; Masci PP; Whitaker AN
    Am J Clin Pathol; 1986 Mar; 85(3):360-4. PubMed ID: 2875646
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Conventional detection method of fibrinogen and fibrin degradation products using latex piezoelectric immunoassay.
    Aizawa H; Kurosawa S; Tozuka M; Park JW; Kobayashi K; Tanaka H
    Biosens Bioelectron; 2003 May; 18(5-6):765-71. PubMed ID: 12706590
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monoclonal antibody-based plasma assays for fibrin(ogen) and derivatives, and their clinical relevance.
    Kroneman H; Nieuwenhuizen W; Knot EA
    Blood Coagul Fibrinolysis; 1990; 1(1):91-111. PubMed ID: 2102791
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical significance of urinary fibrinogen degradation products in renal disease: study with two methods and correlation with histological findings of intraglomerular coagulation.
    Loschiavo C; Previato G; Valvo E; Lupo A; Tessitore N; Chiaramonte S; Maschio G
    Nephron; 1981; 28(4):200-3. PubMed ID: 7029322
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Latex-bound antifibrinogen test for plasma fibrinogen assay.
    Castelan DJ; Hirsh J; Martin M
    J Clin Pathol; 1968 Sep; 21(5):638-42. PubMed ID: 5697369
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fibrin degradation products in thrombo-embolic disease.
    Sonnabend D; Cooper D; Fiddes P; Penny R
    Pathology; 1972 Jan; 4(1):47-51. PubMed ID: 4622192
    [No Abstract]   [Full Text] [Related]  

  • 17. False-negative test for fibrinogen--fibrin degradation products.
    Kickler T; Bell WR
    Am J Clin Pathol; 1977 Jul; 68(1):78-80. PubMed ID: 868807
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparisons of hemagglutination inhibition, staphylococcal clumping, and latex agglutination tests for canine fibrinolytic degradation products.
    Chen JP; Williams TK; Legendre AM
    Am J Vet Res; 1981 Dec; 42(12):2049-52. PubMed ID: 7340573
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum fibrin(ogen) degradation products in diagnosis of deep-vein thrombosis and pulmonary embolism after hip surgery.
    Cooke ED; Bowcock SA; Pilcher MF; Ibbotson RM; Gordon YB; Sola CM; Chard T; Ainsworth ME
    Lancet; 1975 Jul; 2(7924):51-4. PubMed ID: 49650
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative sensitivity of two hemagglutination inhibition immunoassays for fibrinolytic degradation products in human serum.
    Chi DS; Chen JP
    Thromb Haemost; 1976 Apr; 35(2):423-36. PubMed ID: 823661
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.